Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences Unit
Your view on OACCU
Overview
What the company does, where it operates, and who runs it.
About Oaktree Acquisition Corp. III Life Sciences Unit
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Zaid Pardesi
- Headquarters
- 333 South Grand Avenue, Los Angeles, CA, US
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Zaid Pardesi
- Headquarters
- 333 South Grand Avenue, Los Angeles, CA, US
Oaktree Acquisition Corp. III Life Sciences operates as a special purpose acquisition company (SPAC). Its primary objective is to execute a strategic business combination—such as a merger, an exchange of capital stock, an asset or stock acquisition, or a broader corporate restructuring—with one or more existing enterprises.
Established in 1995, this company maintains its principal office in Los Angeles, California.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Oaktree Acquisition Corp. III Life Sciences Unit from FRC's valuation model, read against the market price. OACCU last traded at $10.76, 58.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Oaktree Acquisition Corp. III Life Sciences Unit. Starting points for Oaktree Acquisition Corp. III Life Sciences Unit: P/E 58.4, EPS $0.23, beta -0.03 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Oaktree Acquisition Corp. III Life Sciences Unit. Oaktree Acquisition Corp. III Life Sciences Unit does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Oaktree Acquisition Corp. III Life Sciences Unit. Trailing twelve-month EPS for Oaktree Acquisition Corp. III Life Sciences Unit stands at $0.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Oaktree Acquisition Corp. III Life Sciences Unit. Oaktree Acquisition Corp. III Life Sciences Unit has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- BACCBlue Acquisition Corp.Shell Companies$292M
- BDCIUBTC Development Corp. UnitShell Companies$267M
- GIWWUGigCapital8 Corp. UnitsShell Companies$235M
- KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary SharesShell Companies$246M
- NEWTNewtekOne, Inc.Banks - Regional$303M
- NHICNewHold Investment Corp IIIShell Companies$239M
- TLNCUTalon Capital Corp.Shell Companies$267M
More Shell Companies companies
- GSRFGSR IV Acquisition Corp. Class A ordinary shareNASDAQ$244M
- GSRFRGSR IV Acquisition Corp. RightsNASDAQ$244M
- GSRFUGSR IV Acquisition Corp. UnitsNASDAQ$275M
- GSRVGSR V Acquisition Corp.NASDAQ$369M
- GSRVRGSR V Acquisition Corp.NASDAQ$33M
- GSRVUGSR V Acquisition Corp.NASDAQ$239M
- GTENGores Holdings X, Inc.NASDAQ$470M
- GTENUGores Holdings X, Inc. UnitsNASDAQ$470M
- GTENWGores Holdings X, Inc. WarrantsNASDAQ$480M
- GTERUGloba Terra Acquisition CorporationNASDAQ$188M
- GUACBerto Acquisition Corp. IINASDAQ$390M
- GUACUBerto Acquisition Corp. II UnitNASDAQ$77M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Oaktree Acquisition Corp. III Life Sciences Unit, and how their positions are changing. At a $262.8M market value, institutional positions materially move Oaktree Acquisition Corp. III Life Sciences Unit's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Oaktree Acquisition Corp. III Life Sciences Unit executives and directors. Shares of Oaktree Acquisition Corp. III Life Sciences Unit have traded between $10.46 and $12.47 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Oaktree Acquisition Corp. III Life Sciences Unit. Coverage tracks Oaktree Acquisition Corp. III Life Sciences Unit within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Oaktree Acquisition Corp. III Life Sciences Unit.